Article

Orphan Drug Cost Controversy Highlights AJPB Week in Review

Author(s):

Davy James, Managing Editor

Top articles of the week from The American Journal of Pharmacy Benefits.

Related Videos
3 experts are featured in this series.
3 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
California Wildfires, Pharmacies, Community | image Credit: J Bettencourt/peopleimages.com | stock.adobe.com
California Wildfire, Pharmacy, Community | Image Credit: Erin | stock.adobe.com
Allergies, Asthma, Biologic Treatment, Pharmacists | Image Credit: Pixel-Shot | stock.adobe.com
Related Content
Blast cell in Acute myeloid leukemia from human blood cells (White blood cells cancer , Bone marrow aspirate)
January 22nd 2025

FDA Approves Treosulfan Regimen For Preparative Use in Stem Cell Transplantation Patients With AML, MDS

Luke Halpern, Assistant Editor
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
December 24th 2024

Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health

Christina M. Madison, PharmD, FCCP, AAHIVP
Benjamin Franklin on US dollar surrounded by pills | Image Credit: © Cagkan - stock.adobe.com
January 22nd 2025

Reversal of Executive Order 14087 Raises Questions About Future Drug Pricing Reforms

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
December 23rd 2024

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Alexandra Gerlach, Associate Editor
Oncology pharmacist, Breast Cancer, Oncology, Treatment | Image Credit: Dragana Gordic | stock.adobe.com
January 22nd 2025

Advancing Precision Oncology: The Role of Targeted Therapies in HR+, HER2– Breast Cancer

Ashley Gallagher, Editor
High Sensitivity C-Reactive Protein, High-Density Lipoprotein Cholesterol, All-Cause Mortality | Image Credit: SK imagine | stock.adobe.com
January 22nd 2025

High-Sensitivity C-Reactive Protein/High-Density Lipoprotein Cholesterol Ratio Predicts Long-Term Mortality

Ashley Gallagher, Editor